EcoDrugPlus

Estrogen Receptor Beta

Ensembl ID : ENSSAUG00010012071
Gene Symbol: LOC115574485
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSSAUG00010016030
Gene Symbol: LOC115597332
3 Cross references
208 Possible Orthologues:

Estrogen-Related Receptor Gamma

Ensembl ID : ENSSAUG00010010195
Gene Symbol: LOC115580589
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSAUG00010000126
Gene Symbol: XPO1
1 Cross references
224 Possible Orthologues:

Exportin 1

Ensembl ID : ENSSAUG00010011605
Gene Symbol: XPO1
1 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSSAUG00010015664
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSSAUG00010003090
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSSAUG00010024226
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSAUG00010011246
Gene Symbol: FGFR1
3 Cross references
204 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSSAUG00010011744
Gene Symbol: FGFR1
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSSAUG00010018345
Gene Symbol: FGFR2
1 Cross references
214 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSSAUG00010021636
Gene Symbol: FGFR3
1 Cross references
192 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).